公司資料
Zimmer Biomet 股價、新聞與催化劑
- 股票代碼:
- ZBH
- 交易所:
- NYSE
- 產業:
- MedTech
- 所在地:
- United States
股票表現
88.06 USD (-0.87%)
收盤價
最後更新: 2026年10月1日
16.2B USD
市值
股價為何變動
截至 2026年10月1日，ZBH 下跌 0.87%，收於 $88.06。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Musculoskeletal Medical Technology Company
Zimmer Biomet develops implants, instruments, robotics, and digital technologies used to restore mobility and treat musculoskeletal disease. Its portfolio serves orthopedic surgeons, hospitals, ambulatory surgery centers, and patients across joint reconstruction and related procedures.
Knee and Hip Reconstruction
The company's largest franchises include knee and hip implants, revision systems, and enabling instruments. These products address primary and complex joint replacement and are supported by surgeon training, procedure planning, and a large field organization.
S.E.T. and Other Orthopedic Solutions
The S.E.T. portfolio spans sports medicine, extremities, trauma, craniomaxillofacial, and thoracic products. This broadens Zimmer Biomet beyond large joints and provides access to faster-growing procedure categories.
ROSA Robotic Surgery Platform
ROSA systems support robotic assistance in knee, hip, and shoulder procedures. The platform combines preoperative planning, intraoperative data, and surgical execution and creates opportunities for software, service, and implant pull-through.
Digital Care and Data Strategy
Zimmer Biomet integrates connected devices, data analytics, artificial intelligence, and remote-care tools around orthopedic episodes. These technologies are intended to improve surgical planning, patient engagement, recovery monitoring, and operating-room efficiency.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。